State Street
BNTX icon

State Street’s BioNTech BNTX Stock Holding History

State Street’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Sell
163,537
-17,095
-9% -$1.61M ﹤0.01% 2502
2026
Q1 		$16.1M Buy
180,632
+30,255
+20% +$3.11M ﹤0.01% 2354
2025
Q4 		$14.3M Buy
150,377
+23,742
+19% +$2.39M ﹤0.01% 2436
2025
Q3 		$12.5M Sell
126,635
-18,674
-13% -$2M ﹤0.01% 2513
2025
Q2 		$15.5M Sell
145,309
-7,602
-5% -$768K ﹤0.01% 2328
2025
Q1 		$13.9M Buy
152,911
+5,367
+4% +$601K ﹤0.01% 2324
2024
Q4 		$16.8M Sell
147,544
-8,323
-5% -$950K ﹤0.01% 2311
2024
Q3 		$18.5M Buy
155,867
+3,014
+2% +$277K ﹤0.01% 2254
2024
Q2 		$12.3M Buy
152,853
+11,404
+8% +$1.04M ﹤0.01% 2437
2024
Q1 		$13M Buy
141,449
+9,246
+7% +$887K ﹤0.01% 2422
2023
Q4 		$14M Buy
132,203
+3,780
+3% +$381K ﹤0.01% 2404
2023
Q3 		$14M Buy
128,423
+2,370
+2% +$262K ﹤0.01% 2399
2023
Q2 		$13.6M Buy
126,053
+1,394
+1% +$157K ﹤0.01% 2472
2023
Q1 		$15.5M Buy
124,659
+4,806
+4% +$660K ﹤0.01% 2389
2022
Q4 		$18M Buy
119,853
+13,268
+12% +$2.04M ﹤0.01% 2317
2022
Q3 		$14.4M Buy
106,585
+2,662
+3% +$407K ﹤0.01% 2479
2022
Q2 		$15.5M Sell
103,923
-8,313
-7% -$1.27M ﹤0.01% 2429
2022
Q1 		$19.1M Buy
112,236
+55,162
+97% +$9.27M ﹤0.01% 2447
2021
Q4 		$14.7M Buy
57,074
+5,517
+11% +$1.51M ﹤0.01% 2679
2021
Q3 		$14.1M Buy
51,557
+42,747
+485% +$13.6M ﹤0.01% 2687
2021
Q2 		$1.97M Buy
8,810
+1,031
+13% +$194K ﹤0.01% 3551
2021
Q1 		$849K Buy
7,779
+179
+2% +$19K ﹤0.01% 3657
2020
Q4 		$620K Buy
+7,600
New +$746K ﹤0.01% 3626

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

State Street's BNTX Position: Q2 2026 in Review

State Street reduced its BioNTech (BNTX) stake by 9.5% in Q2 2026, selling an estimated $1.61M and leaving 163,537 shares worth $15.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

State Street first reported a position in BNTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $19.1M in Q1 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • State Street held 163,537 shares of BioNTech worth $15.2M as of Q2 2026.
  • State Street sold 17,095 BioNTech shares in Q2 2026, an estimated $1.61M.
  • BioNTech made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2502 holding.
  • State Street first reported a position in BioNTech in Q4 2020 and has held it in 23 quarters since.
  • State Street's BioNTech position peaked at $19.1M in Q1 2022.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.